# Role of N-Acetylcysteine for Prevention of Cisplatin-induced Nephrotoxicity

> **NCT06019520** · NA · UNKNOWN · sponsor: **Foundation University Islamabad** · enrollment: 70 (estimated)

## Conditions studied

- Drug Toxicity

## Interventions

- **DRUG:** N-Acetylcysteine
- **DRUG:** Chemotherapy

## Key facts

- **NCT ID:** NCT06019520
- **Lead sponsor:** Foundation University Islamabad
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-08-09
- **Primary completion:** 2024-02-09
- **Final completion:** 2024-03-09
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2023-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06019520

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06019520, "Role of N-Acetylcysteine for Prevention of Cisplatin-induced Nephrotoxicity". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06019520. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*